{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:45:34Z","timestamp":1776807934078,"version":"3.51.2"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.medcli.2017.07.020","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T11:01:12Z","timestamp":1507806072000},"page":"226-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hiperparatiroidismo primario"],"prefix":"10.1016","volume":"150","author":[{"given":"Manuel","family":"Mu\u00f1oz-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.07.020_bib0290","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"19","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.medcli.2017.07.020_bib0295","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice. Primary hyperparathyroidism","volume":"365","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0300","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: A \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0305","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjmed.2004.06.037","article-title":"Characterization of normocalcemic primary hyperparathyroidism","volume":"117","author":"Tordjman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0310","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalceminc primary hyperparathyroidism: Further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0315","first-page":"438","article-title":"Primary hyperparathyroidism: diagnosis and management in 2017","volume":"127","author":"Syed","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0320","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0325","first-page":"N68","article-title":"Clinical presentation of primary hyperparathyroidism in Europe: Nationwide cohort analysis on mortality from nonmalignant causes","volume":"Suppl 2","author":"Nilsson","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.medcli.2017.07.020_bib0330","first-page":"957","article-title":"Results from a national survey on the management of primary hyperparathyroidism","volume":"35","author":"Mu\u00f1oz Torres","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.medcli.2017.07.020_bib0335","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1026518502081","article-title":"Molecular mechanisms of primary hyperparathyroidism","volume":"1","author":"Hendy","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.medcli.2017.07.020_bib0340","first-page":"30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.medcli.2017.07.020_bib0345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet."},{"key":"10.1016\/j.medcli.2017.07.020_bib0350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","article-title":"Multiple endocrine neoplasia type 2","volume":"24","author":"Wohllk","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0355","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.medcli.2017.07.020_bib0360","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric hypercalcemia: A review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.medcli.2017.07.020_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: Review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.medcli.2017.07.020_bib0370","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/bmj.325.7368.807","article-title":"The risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: A controlled historical follow up study","volume":"325","author":"Mollerup","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2017.07.020_bib0375","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0380","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00268-002-6433-2","article-title":"Multifactorial risk profile for bone fractures in primary hyperparathyroidism","volume":"26","author":"Nordenstrom","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.medcli.2017.07.020_bib0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ecl.2016.09.012","article-title":"Primary hyperparathyroidism: Effects on bone health","volume":"46","author":"Zanocco","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.medcli.2017.07.020_bib0390","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00268-002-6589-9","article-title":"Fractures in patients with primary hyperparathyroidism: Nationwide follow-up study of 1.201 patients","volume":"27","author":"Estergaard","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.medcli.2017.07.020_bib0395","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1138\/20110524","article-title":"The treatment of primary hyperparathyroidism","volume":"8","author":"J\u00f3dar Gimeno","year":"2011","journal-title":"IBMS BoneKEy"},{"key":"10.1016\/j.medcli.2017.07.020_bib0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1477-7525-11-97","article-title":"Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism","volume":"18","author":"Webb","year":"2013","journal-title":"Health Qual Life Outcomes."},{"key":"10.1016\/j.medcli.2017.07.020_bib0405","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/jc.2015-3094","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0410","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF03346443","article-title":"Cardiovascular aspects of primary hyperparathyroidism","volume":"31","author":"Walker","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.medcli.2017.07.020_bib0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/10641960903254471","article-title":"Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure profile in primary hyperparathyroidism","volume":"32","author":"Feldstein","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.medcli.2017.07.020_bib0420","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg."},{"key":"10.1016\/j.medcli.2017.07.020_bib0425","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-5491.2002.00809.x","article-title":"The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism","volume":"19","author":"Procopio","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0430","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/BF03345264","article-title":"Derangement of glucose metabolism in hyperparathyroidism","volume":"26","author":"Procopio","year":"2003","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.medcli.2017.07.020_bib0435","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2017.07.020_bib0440","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0445","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: A prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0450","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2017.07.020_bib0455","first-page":"e1","article-title":"Normocalcemic primary hyperparathyroidism: Recommendations for management and follow-up","volume":"60","author":"Mart\u00ednez D\u00edaz-Guerra","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.medcli.2017.07.020_bib0460","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.clinbiochem.2012.04.025","article-title":"Investigation of hypercalcemia","volume":"45","author":"Endres","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.medcli.2017.07.020_bib0465","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2002-021266","article-title":"Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2017.07.020_bib0470","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0475","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0480","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MED.0b013e32834b4401","article-title":"Mechanism and treatment of hypercalcemia of malignancy","volume":"18","author":"Clines","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.medcli.2017.07.020_bib0485","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.1721","article-title":"Indications for surgical management of hyperparathyroidism: A review","author":"Stephen","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.medcli.2017.07.020_bib0490","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2967\/jnumed.107.050237","article-title":"Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism","volume":"49","author":"Judson","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0495","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2012-3168","article-title":"Clinical review: Parathyroid localization and implications for clinical management","volume":"98","author":"Kunstman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0500","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-200005000-00014","article-title":"Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism","volume":"231","author":"Goldstein","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.medcli.2017.07.020_bib0505","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00268-008-9479-y","article-title":"Minimally invasive videoassisted thyroidectomy for benign thyroid disease: An evidence-based review","volume":"32","author":"Miccoli","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/j.medcli.2017.07.020_bib0510","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-016-1169-1","article-title":"Vitamin D and primary hyperparathyroidism: More insights into a complex relationship","volume":"55","author":"Walker","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.medcli.2017.07.020_bib0515","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","article-title":"Vitamin D treatment in primary hyperparathyroidism: A randomized placebo controlled trial","volume":"99","author":"Rolighed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0520","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2017.07.020_bib0525","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0530","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.medcli.2017.07.020_bib0535","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0540","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0545","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2362.2007.01874.x","article-title":"The role of calcimimetics in the treatment of hyperparathyroidism","volume":"37","author":"W\u00fcthrich","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.medcli.2017.07.020_bib0550","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.metabol.2007.11.014","article-title":"Cinacalcet for the treatment of primary hyperparathyroidism","volume":"57","author":"Sajid-Crockett","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.medcli.2017.07.020_bib0555","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-14-0355","article-title":"The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice","volume":"171","author":"Schwarz","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2017.07.020_bib0560","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2042018813482344","article-title":"Experience with cinacalcet in primary hyperparathyroidism: Results after 1 year of treatment","volume":"4","author":"Luque-Fern\u00e1ndez","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.medcli.2017.07.020_bib0565","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-13-0305","article-title":"Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2017.07.020_bib0570","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0885066613507530","article-title":"Hypercalcemia in the intensive care unit: A review of pathophysiology, diagnosis, and modern therapy","volume":"30","author":"Maier","year":"2015","journal-title":"J Intensive Care Med"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317306474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T17:56:39Z","timestamp":1603130199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317306474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0025775317306474"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.020","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperparatiroidismo primario","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}